Low-dose Ara-C in the treatment of myelodysplastic syndromes.
Bogdanić
V
V
Department of Medicine, Clinical Hospital Center-Rebro, Zagreb, Yugoslavia.
Labar
B
B
Mrsić
M
M
Nemet
D
D
Serventi-Seiwerth
R
R
D003561:Cytarabine / Q000008:administration & dosage*; D006801:Humans; D009190:Myelodysplastic Syndromes / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic
D003561:Cytarabine